- Home
- ALZN vs EVOK Comparison
ALZN vs EVOK Comparison
Compare ALZN & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- EVOK
- Stock Information
- Founded
- ALZN 2016
- EVOK 2007
- Country
- ALZN United States
- EVOK United States
- Employees
- ALZN N/A
- EVOK N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- ALZN Health Care
- EVOK Health Care
- Exchange
- ALZN Nasdaq
- EVOK Nasdaq
- Market Cap
- ALZN 6.1M
- EVOK 6.5M
- IPO Year
- ALZN 2021
- EVOK 2013
- Fundamental
- Price
- ALZN $1.17
- EVOK $4.47
- Analyst Decision
- ALZN Strong Buy
- EVOK
- Analyst Count
- ALZN 1
- EVOK 0
- Target Price
- ALZN $32.00
- EVOK N/A
- AVG Volume (30 Days)
- ALZN 145.7K
- EVOK 29.5K
- Earning Date
- ALZN 12-12-2024
- EVOK 03-13-2025
- Dividend Yield
- ALZN N/A
- EVOK N/A
- EPS Growth
- ALZN N/A
- EVOK N/A
- EPS
- ALZN N/A
- EVOK N/A
- Revenue
- ALZN N/A
- EVOK $8,617,036.00
- Revenue This Year
- ALZN N/A
- EVOK $97.35
- Revenue Next Year
- ALZN N/A
- EVOK $99.52
- P/E Ratio
- ALZN N/A
- EVOK N/A
- Revenue Growth
- ALZN N/A
- EVOK 100.35
- 52 Week Low
- ALZN $1.06
- EVOK $3.54
- 52 Week High
- ALZN $15.06
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- ALZN 45.87
- EVOK 47.52
- Support Level
- ALZN $1.13
- EVOK $4.30
- Resistance Level
- ALZN $1.23
- EVOK $4.58
- Average True Range (ATR)
- ALZN 0.06
- EVOK 0.26
- MACD
- ALZN 0.01
- EVOK -0.00
- Stochastic Oscillator
- ALZN 37.20
- EVOK 48.22
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.